Botanix Pharmaceuticals
(ASX) BOT
Botanix Pharmaceuticals Financials at a Glance
Market Cap
$82.07M
Revenue (TTM)
$23.99M
Net Income (TTM)
$127.99M
EPS (TTM)
$-0.05
P/E Ratio
-0.79
Dividend
$0.00
Beta (Volatility)
0.12 (Low)
Dividend
$0.00
Beta (Volatility)
0.12 (Low)
Price
$0.04
Volume
23,939,096
Open
$0.04
Price
$0.04
Volume
23,939,096
Open
$0.04
Previous Close
$0.04
Daily Range
$0.04 - $0.04
52-Week Range
$0.04 - $0.47
Dividend
$0.00
Beta (Volatility)
0.12 (Low)
Price
$0.04
Volume
23,939,096
Open
$0.04
Previous Close
$0.04
Daily Range
$0.04 - $0.04
52-Week Range
$0.04 - $0.47
BOT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Botanix Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareCEO
Howie McKibbon, PharmD
Website
www.botanixpharma.comHeadquarters
Leederville, WA 6007, AU
BOT Financials
Key Financial Metrics (TTM)
Gross Margin
-1%
Operating Margin
-4%
Net Income Margin
-4%
Return on Equity
-121%
Return on Capital
-1%
Return on Assets
-90%
Earnings Yield
-1.27%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$82.07M
Shares Outstanding
2.22B
Volume
23.94M
Short Interest
0.00%
Avg. Volume
14.22M
Financials (TTM)
Gross Profit
$2.02M
Operating Income
$80.79M
EBITDA
$80.65M
Operating Cash Flow
$78.58M
Capital Expenditure
$286.43K
Free Cash Flow
$78.87M
Cash & ST Invst.
$64.97M
Total Debt
$32.51M
Botanix Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$16.51M
+4267.4%
Gross Profit
$28.76M
-850.8%
Gross Margin
-1.74%
N/A
Market Cap
$82.07M
N/A
Market Cap/Employee
$7.46M
N/A
Employees
11
N/A
Net Income
$33.20M
-507.2%
EBITDA
$32.43M
-487.8%
Quarterly Fundamentals
Net Cash
$942.97K
-94.9%
Accounts Receivable
$5.70M
+2497.1%
Inventory
$27.51M
+778.3%
Long Term Debt
$17.54M
N/A
Short Term Debt
$13.13M
N/A
Return on Assets
-89.99%
N/A
Return on Invested Capital
-1.18%
N/A
Free Cash Flow
$32.64M
-76.1%
Operating Cash Flow
$32.64M
-768.0%